Key result
Down's syndrome is linked to higher triglycerides and apoB, failing to explain lower atheromatosis rates.
Why the study?
Do plasma lipid and lipoprotein profiles differ between patients with Down's syndrome and age-matched mentally retarded controls?
Cross-Sectional (n=40)
No
Do plasma lipid and lipoprotein profiles differ between patients with Down's syndrome and age-matched mentally retarded controls?
Patients with Down's syndrome have higher triglyceride and apolipoprotein B levels compared to other mentally retarded patients, which does not explain their reported lower risk of atheromatosis.
Answers are grounded in this paper and cite their sources.
Does not explain atheromatosis protection despite higher triglycerides and apoB; leaves open non-lipid mechanisms for study.
Since mongoloids have been reported to differ from other patients with mental retardation by being virtually free of atheromatosis, we analysed plasma lipids and lipoproteins in twenty mongoloid and in twenty age-matched non-mongoloid mentally retarded patients living in the same institution. Plasma total cholesterol in the mongoloids did not differ significantly from that of the control group, but it was low in both groups in comparison with the Finnish population in general. Plasma total triglyceride concentration was higher (P less than 0.01) in the mongoloids than in the controls. This was reflected in higher VLDL-triglyceride and-cholesterol concentrations in the mongoloids. Plasma apolipoprotein B levels were higher (P less than 0.05) and the ratio of apolipoprotein A-1 to apolipoprotein B was lower (less than 0.05) in the mongoloids. The plasma lipid concentrations were in accordance with the significantly higher relative body weights in the mongoloid group. Blood pressure was slightly but significantly lower and cigarette smoking was less common in patients with Down's syndrome. Our results did not explain the reported lower frequency of atheromatosis in Down's syndrome.
No takes yet. Share an insight, caveat, or question.
Salo et al. (1979) conducted a cross-sectional in Down's syndrome (n=40). Down's syndrome vs. Age-matched non-mongoloid mentally retarded patients was evaluated on Plasma total triglyceride concentration (p=<0.01). Patients with Down's syndrome had higher plasma total triglycerides (P<0.01) and apolipoprotein B levels (P<0.05) than controls, which does not explain their lower frequency of atheromatosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: